Abstract
AbstractAddressing the many challenges posed by rare diseases to patients, families, and society at large demands a specific national (as well as transnational) focus. Historically, the practice of elaborating and adopting national plans and strategies for rare diseases, following a request from the European Commission in 2009, has been an essential means of ensuring this focus, with 25 European Member States having adopted a plan or strategy at some stage. However, from the vantage point of late 2020, there are signs that momentum and commitment to the development, implementation, and renewal of national plans is waning, in some cases. In this article, we examine the status quo and explore the trend for national plans and strategies to expire without clear commitments or timelines for replacement. We also examine the factors and institutions which supported the initial drive towards the adoption of national plans and strategies in Europe and consider the very different climate in which the next generation of national policies may—or may not—be shaped.
Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Public Health, Environmental and Occupational Health,Epidemiology
Reference28 articles.
1. Aymé S, Rodwell C (2014) The European Union Committee of Experts on Rare Diseases: three productive years at the service of the rare disease community. Orphanet J Rare Dis 9:30. https://doi.org/10.1186/1750-1172-9-30
2. Board of Member States of ERNs (2018) Annex to the Statement of the ERN Board of Member States on Integration of the European Reference Networks to the healthcare systems of Member States https://ec.europa.eu/health/sites/health/files/ern/docs/integration_healthcaresystems_annex_en.pdf Accessed August 2020
3. Castro R, Senecat J, de Chalendar M, Vajda I, van Breukelen S, Montefusco M, Nielsen SJ, Dan D (2017) Rare Diseases. In: Amelung V, Stein V, Goodwin N, Balicer R, Nolte E, Suter E (eds) Handbook Integrated Care. Springer, Cham. https://doi.org/10.1007/978-3-319-56103-5_25
4. Castro R, Berjonneau E, Courbier S (2021) Learning from the pandemic to improve care for vulnerable communities: the perspectives and recommendations from the rare disease community. International Journal of Integrated Care 21(1). https://doi.org/10.5334/ijic.5812
5. Commission Expert Group on Rare Diseases (2015) Cross-border genetic testing of rare diseases in the European Union https://ec.europa.eu/health/sites/health/files/rare_diseases/docs/2015_recommendation_crossbordergenetictesting_en.pdf Accessed 20th November 2020
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献